Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Dawson

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Neurology|June 1, 1986
Immunologic responses of progressive multiple sclerosis patients treated with an anti-T-cell monoclonal antibody, anti-T12D A Hafler, R J Fallis, D M Dawson, et al.
Annals of the New York Academy of Sciences|January 1, 1988
Cumulative experience with high-dose intravenous cyclophosphamide and ACTH therapy in chronic progressive multiple sclerosisJ L Carter, D M Dawson, D A Hafler, et al.
Science (New York, N.Y.)|February 26, 1993
Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosisH L Weiner, G A Mackin, M Matsui, et al.
Journal of Cutaneous Pathology|October 1, 1992
Bubble hairD M Elston, W F Bergfeld, D A Whiting, et al.
American Journal of Human Genetics|July 1, 1996
A familial factor independent of CAG repeat length influences age at onset of Machado-Joseph diseaseA L DeStefano, L A Cupples, P Maciel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 5, 2000
Treatment of progressive multiple sclerosis with pulse cyclophosphamide/methylprednisolone: response to therapy is linked to the duration of progressive diseaseM J Hohol, M J Olek, E J Orav, et al.
American Journal of Human Genetics|July 1, 1995
Correlation between CAG repeat length and clinical features in Machado-Joseph diseaseP Maciel, C Gaspar, A L DeStefano, et al.
The Journal of Urology|April 1, 1987
Chromosome abnormalities in Peyronie's diseaseK D Somers, B A Winters, D M Dawson, et al.
The New England Journal of Medicine|January 27, 1983
Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTHS L Hauser, D M Dawson, J R Lehrich, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 1, 1984
The natural history of Machado-Joseph disease. An analysis of 138 personally examined casesA Barbeau, M Roy, L Cunha, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Neurology|June 1, 1986
Immunologic responses of progressive multiple sclerosis patients treated with an anti-T-cell monoclonal antibody, anti-T12D A Hafler, R J Fallis, D M Dawson, et al.
Annals of the New York Academy of Sciences|January 1, 1988
Cumulative experience with high-dose intravenous cyclophosphamide and ACTH therapy in chronic progressive multiple sclerosisJ L Carter, D M Dawson, D A Hafler, et al.
Science (New York, N.Y.)|February 26, 1993
Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosisH L Weiner, G A Mackin, M Matsui, et al.
Journal of Cutaneous Pathology|October 1, 1992
Bubble hairD M Elston, W F Bergfeld, D A Whiting, et al.
American Journal of Human Genetics|July 1, 1996
A familial factor independent of CAG repeat length influences age at onset of Machado-Joseph diseaseA L DeStefano, L A Cupples, P Maciel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 5, 2000
Treatment of progressive multiple sclerosis with pulse cyclophosphamide/methylprednisolone: response to therapy is linked to the duration of progressive diseaseM J Hohol, M J Olek, E J Orav, et al.
American Journal of Human Genetics|July 1, 1995
Correlation between CAG repeat length and clinical features in Machado-Joseph diseaseP Maciel, C Gaspar, A L DeStefano, et al.
The Journal of Urology|April 1, 1987
Chromosome abnormalities in Peyronie's diseaseK D Somers, B A Winters, D M Dawson, et al.
The New England Journal of Medicine|January 27, 1983
Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTHS L Hauser, D M Dawson, J R Lehrich, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 1, 1984
The natural history of Machado-Joseph disease. An analysis of 138 personally examined casesA Barbeau, M Roy, L Cunha, et al.
Pageof 8